+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Rotavirus Prophylaxis Market Report 2026 - Product Thumbnail Image

Rotavirus Prophylaxis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Inactivated Vaccines Market Report 2026 - Product Thumbnail Image

Inactivated Vaccines Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Vaccine Adjuvants Market Report 2026 - Product Thumbnail Image

Vaccine Adjuvants Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Pneumococcal Vaccine Market Report 2026 - Product Thumbnail Image

Pneumococcal Vaccine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Synthetic Biology Market Report 2024-2034 - Product Thumbnail Image

Synthetic Biology Market Report 2024-2034

  • Report
  • July 2024
  • 402 Pages
  • Global
From
From
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • April 2026
  • 211 Pages
  • Global
From
Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 462 Pages
  • Global
From
From
Loading Indicator